Dendritic cells and their role in periodontal disease

Oral Diseases

Volumn 20, Issue 2, 2014, Pages 119-126

  Wilensky, A ^a   Segev, H ^a   Mizraji, G ^a   Shaul, Y ^a   Capucha, T ^a   Shacham, M ^a   Hovav, A H ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Dendritic cells; Gingiva; Oral mucosa; Periodontitis; T cells

Indexed keywords

ANIMAL; CHRONIC DISEASE; CYTOLOGY; DENDRITIC CELL; HUMAN; MOUTH MUCOSA; PERIODONTAL DISEASES; PERIODONTITIS; PHYSIOLOGY;

ANIMALS; CHRONIC DISEASE; DENDRITIC CELLS; HUMANS; MOUTH MUCOSA; PERIODONTAL DISEASES; PERIODONTITIS;

EID: 84893796815     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/odi.12122     Document Type: Review

References (97)

1. Allam JP, Novak N, Fuchs C et al (2003). Characterization of dendritic cells from human oral mucosa: a new Langerhans' cell type with high constitutive FcepsilonRI expression. J Allergy Clin Immunol 112: 141-148.
2. Allam JP, Stojanovski G, Friedrichs N et al (2008). Distribution of Langerhans cells and mast cells within the human oral mucosa: new application sites of allergens in sublingual immunotherapy? Allergy 63: 720-727.
3. Aramaki O, Chalermsarp N, Otsuki M, Tagami J, Azuma M (2011). Differential expression of co-signal molecules and migratory properties in four distinct subsets of migratory dendritic cells from the oral mucosa. Biochem Biophys Res Commun 413: 407-413.
4. Arizon M, Nudel I, Segev H et al (2012). Langerhans cells down-regulate inflammation-driven alveolar bone loss. Proc Natl Acad Sci U S A 109: 7043-7048.
5. Baker PJ, Dixon M, Evans RT, Dufour L, Johnson E, Roopenian DC (1999). CD4(+) T cells and the proinflammatory cytokines gamma interferon and interleukin-6 contribute to alveolar bone loss in mice. Infect Immun 67: 2804-2809.
6. Banchereau J, Steinman RM (1998). Dendritic cells and the control of immunity. Nature 392: 245-252.
7. Benakanakere M, Kinane DF (2012). Innate cellular responses to the periodontal biofilm. Front Oral Biol 15: 41-55.
8. Bodineau A, Coulomb B, Folliguet M et al (2007). Do Langerhans cells behave similarly in elderly and younger patients with chronic periodontitis? Arch Oral Biol 52: 189-194.
9. Brissette CA, Pham TT, Coats SR, Darveau RP, Lukehart SA (2008). Treponema denticola does not induce production of common innate immune mediators from primary gingival epithelial cells. Oral Microbiol Immunol 23: 474-481.
10. Brown LJ, Loe H (1993). Prevalence, extent, severity and progression of periodontal disease. Periodontol 2000: 57-71.
11. Caetano-Lopes J, Canhao H, Fonseca JE (2009). Osteoimmunology-the hidden immune regulation of bone. Autoimmun Rev 8: 250-255.
12. Chalermsarp N, Azuma M (2009). Identification of three distinct subsets of migrating dendritic cells from oral mucosa within the regional lymph nodes. Immunology 127: 558-566.
13. Chaushu S, Wilensky A, Gur C et al (2012). Direct recognition of Fusobacterium nucleatum by the NK cell natural cytotoxicity receptor NKp46 aggravates periodontal disease. PLoS Pathog 8: e1002601.
14. Chino T, Santer DM, Giordano D et al (2009). Effects of oral commensal and pathogenic bacteria on human dendritic cells. Oral Microbiol Immunol 24: 96-103.
15. Crawford JM, Krisko JM, Morris GA, Chambers DA (1989). The distribution of Langerhans cells and CD1a antigen in healthy and diseased human gingiva. Reg Immunol 2: 91-97.
16. Cury PR, Furuse C, Rodrigues AE, Barbuto JA, Araujo VC, Araujo NS (2008). Interstitial and Langerhans' dendritic cells in chronic periodontitis and gingivitis. Braz Oral Res 22: 258-263.
17. Daniels TE (1984). Human mucosal Langerhans cells: postmortem identification of regional variations in oral mucosa. J Invest Dermatol 82: 21-24.
18. Deo V, Bhongade ML (2010). Pathogenesis of periodontitis: role of cytokines in host response. Dent Today 29: 60-62, 64-6; quiz 68-9.
19. Dereka XE, Tosios KI, Chrysomali E, Angelopoulou E (2004). Factor XIIIa+ dendritic cells and S-100 protein+ Langerhans' cells in adult periodontitis. J Periodontal Res 39: 447-452.
20. Eskan MA, Benakanakere MR, Rose BG et al (2008a). Interleukin-1beta modulates proinflammatory cytokine production in human epithelial cells. Infect Immun 76: 2080-2089.
21. Eskan MA, Rose BG, Benakanakere MR et al (2008b). TLR4 and S1P receptors cooperate to enhance inflammatory cytokine production in human gingival epithelial cells. Eur J Immunol 38: 1138-1147.
22. Gaffen SL, Hajishengallis G (2008). A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17. J Dent Res 87: 817-828.
23. Garlet GP (2010). Destructive and protective roles of cytokines in periodontitis: a re-appraisal from host defense and tissue destruction viewpoints. J Dent Res 89: 1349-1363.
24. Garlet GP, Cardoso CR, Mariano FS et al (2010). Regulatory T cells attenuate experimental periodontitis progression in mice. J Clin Periodontol 37: 591-600.
25. Gemmell E, Carter CL, Hart DN, Drysdale KE, Seymour GJ (2002a). Antigen-presenting cells in human periodontal disease tissues. Oral Microbiol Immunol 17: 388-393.
26. Gemmell E, Yamazaki K, Seymour GJ (2002b). Destructive periodontitis lesions are determined by the nature of the lymphocytic response. Crit Rev Oral Biol Med 13: 17-34.
27. Genco RJ, Grossi SG, Ho A, Nishimura F, Murayama Y (2005). A proposed model linking inflammation to obesity, diabetes, and periodontal infections. J Periodontol 76: 2075-2084.
28. Graves D (2008). Cytokines that promote periodontal tissue destruction. J Periodontol 79: 1585-1591.
29. Hajishengallis G, Liang S, Payne MA et al (2011). Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe 10: 497-506.
30. Hans M, Hans VM (2011). Toll-like receptors and their dual role in periodontitis: a review. J Oral Sci 53: 263-271.
31. Hasseus B, Jontell M, Bergenholtz G, Eklund C, Dahlgren UI (1999). Langerhans cells from oral epithelium are more effective in stimulating allogeneic t-cells in vitro than Langerhans cells from skin epithelium. J Dent Res 78: 751-758.
32. Hasseus B, Jontell M, Bergenholtz G, Dahlgren UI (2004). Langerhans cells from human oral epithelium are more effective at stimulating allogeneic T cells in vitro than Langerhans cells from skin. Clin Exp Immunol 136: 483-489.
33. Heath WR, Carbone FR (2009). Dendritic cell subsets in primary and secondary T cell responses at body surfaces. Nat Immunol 10: 1237-1244.
34. Helft J, Ginhoux F, Bogunovic M, Merad M (2010). Origin and functional heterogeneity of non-lymphoid tissue dendritic cells in mice. Immunol Rev 234: 55-75.
35. Hervouet C, Luci C, Rol N et al (2010). Langerhans cells prime IL-17-producing T cells and dampen genital cytotoxic responses following mucosal immunization. J Immunol 184: 4842-4851.
36. Huang CB, Altimova Y, Strange S, Ebersole JL (2011). Polybacterial challenge effects on cytokine/chemokine production by macrophages and dendritic cells. Inflamm Res 60: 119-125.
37. Ito H, Takekoshi T, Miyauchi M et al (1998). Three-dimensional appearance of Langerhans cells in human gingival epithelium as revealed by confocal laser scanning microscopy. Arch Oral Biol 43: 741-744.
38. Jenkinson HF, Lamont RJ (2005). Oral microbial communities in sickness and in health. Trends Microbiol 13: 589-595.
39. Jotwani R, Cutler CW (2003). Multiple dendritic cell (DC) subpopulations in human gingiva and association of mature DCs with CD4+ T-cells in situ. J Dent Res 82: 736-741.
40. Jotwani R, Palucka AK, Al-Quotub M et al (2001). Mature dendritic cells infiltrate the T cell-rich region of oral mucosa in chronic periodontitis: in situ, in vivo, and in vitro studies. J Immunol 167: 4693-4700.
41. Jotwani R, Pulendran B, Agrawal S, Cutler CW (2003). Human dendritic cells respond to Porphyromonas gingivalis LPS by promoting a Th2 effector response in vitro. Eur J Immunol 33: 2980-2986.
42. Jotwani R, Eswaran SV, Moonga S, Cutler CW (2010). MMP-9/TIMP-1 imbalance induced in human dendritic cells by Porphyromonas gingivalis. FEMS Immunol Med Microbiol 58: 314-321.
43. Kanaya S, Nemoto E, Ogawa T, Shimauchi H (2004). Porphyromonas gingivalis lipopolysaccharides induce maturation of dendritic cells with CD14+CD16+ phenotype. Eur J Immunol 34: 1451-1460.
44. Kanaya S, Nemoto E, Ogawa T, Shimauchi H (2009). Porphyromonas gingivalis fimbriae induce unique dendritic cell subsets via Toll-like receptor 2. J Periodontal Res 44: 543-549.
45. Kautz-Neu K, Noordegraaf M, Dinges S et al (2011). Langerhans cells are negative regulators of the anti-Leishmania response. J Exp Med 208: 885-891.
46. Kinane DF, Shiba H, Stathopoulou PG et al (2006). Gingival epithelial cells heterozygous for Toll-like receptor 4 polymorphisms Asp299Gly and Thr399ile are hypo-responsive to Porphyromonas gingivalis. Genes Immun 7: 190-200.
47. Lacey DL, Timms E, Tan HL et al (1998). Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93: 165-176.
48. Leshem O, Kashino SS, Goncalves RB et al (2008). Th1 biased response to a novel Porphyromonas gingivalis protein aggravates bone resorption caused by this oral pathogen. Microbes Infect 10: 664-672.
49. Liang S, Hosur KB, Domon H, Hajishengallis G (2010). Periodontal inflammation and bone loss in aged mice. J Periodontal Res 45: 574-578.
50. Listgarten MA (1986). Pathogenesis of periodontitis. J Clin Periodontol 13: 418-430.
51. Loser K, Mehling A, Loeser S et al (2006). Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat Med 12: 1372-1379.
52. Mascarell L, Lombardi V, Louise A et al (2008). Oral dendritic cells mediate antigen-specific tolerance by stimulating TH1 and regulatory CD4+ T cells. J Allergy Clin Immunol 122: 603-609e5.
53. Monteiro AC, Scovino A, Raposo S et al (2009). Kinin danger signals proteolytically released by gingipain induce Fimbriae-specific IFN-gamma- and IL-17-producing T cells in mice infected intramucosally with Porphyromonas gingivalis. J Immunol 183: 3700-3711.
54. Moughal NA, Adonogianaki E, Kinane DF (1992). Langerhans cell dynamics in human gingiva during experimentally induced inflammation. J Biol Buccale 20: 163-167.
55. Myint M, Yuan ZN, Schenck K (2000). Reduced numbers of Langerhans cells and increased HLA-DR expression in keratinocytes in the oral gingival epithelium of HIV-infected patients with periodontitis. J Clin Periodontol 27: 513-519.
56. Myneni SR, Settem RP, Connell TD, Keegan AD, Gaffen SL, Sharma A (2011). TLR2 signaling and Th2 responses drive Tannerella forsythia-induced periodontal bone loss. J Immunol 187: 501-509.
57. Newcomb GM, Powell RN (1986). Human gingival Langerhans cells in health and disease. J Periodontal Res 21: 640-652.
58. Newcomb GM, Seymour GJ, Powell RN (1982). Association between plaque accumulation and Langerhans cell numbers in the oral epithelium of attached gingiva. J Clin Periodontol 9: 297-304.
59. Nudel I, Elnekave M, Furmanov K et al (2011). Dendritic cells in distinct oral mucosal tissues engage different mechanisms to prime CD8+ T cells. J Immunol 186: 891-900.
60. Nussbaum G, Shapira L (2011). How has neutrophil research improved our understanding of periodontal pathogenesis? J Clin Periodontol 38(Suppl 11): 49-59.
61. Nussbaum G, Ben-Adi S, Genzler T, Sela M, Rosen G (2009). Involvement of Toll-like receptors 2 and 4 in the innate immune response to Treponema denticola and its outer sheath components. Infect Immun 77: 3939-3947.
62. Obhrai JS, Oberbarnscheidt M, Zhang N et al (2008). Langerhans cells are not required for efficient skin graft rejection. J Invest Dermatol 128: 1950-1955.
63. O'Brien-Simpson NM, Pathirana RD, Walker GD, Reynolds EC (2009). Porphyromonas gingivalis RgpA-Kgp proteinase-adhesin complexes penetrate gingival tissue and induce proinflammatory cytokines or apoptosis in a concentration-dependent manner. Infect Immun 77: 1246-1261.
64. Onishi S, Honma K, Liang S et al (2008). Toll-like receptor 2-mediated interleukin-8 expression in gingival epithelial cells by the Tannerella forsythia leucine-rich repeat protein BspA. Infect Immun 76: 198-205.
65. Oseko F, Yamamoto T, Akamatsu Y et al (2009). IL-17 is involved in bone resorption in mouse periapical lesions. Microbiol Immunol 53: 287-294.
66. Page RC, Schroeder HE (1976). Pathogenesis of inflammatory periodontal disease. A summary of current work. Lab Invest 34: 235-249.
67. Papadopoulos G, Weinberg EO, Massari P et al (2012). Macrophage-specific TLR2 signaling mediates pathogen-induced TNF-dependent inflammatory oral bone loss. J Immunol 190: 1148-1157.
68. Paster BJ, Olsen I, Aas JA, Dewhirst FE (2006). The breadth of bacterial diversity in the human periodontal pocket and other oral sites. Periodontol 2000: 80-87.
69. Pulendran B, Kumar P, Cutler CW, Mohamadzadeh M, Van Dyke T, Banchereau J (2001). Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J Immunol 167: 5067-5076.
70. Rimoldi M, Chieppa M, Larghi P, Vulcano M, Allavena P, Rescigno M (2005). Monocyte-derived dendritic cells activated by bacteria or by bacteria-stimulated epithelial cells are functionally different. Blood 106: 2818-2826.
71. Rittman BR, Hill MW, Rittman GA, Mackenzie IC (1987). Age-associated changes in Langerhans cells of murine oral epithelium and epidermis. Arch Oral Biol 32: 885-889.
72. Saglie FR, Pertuiset JH, Smith CT et al (1987). The presence of bacteria in the oral epithelium in periodontal disease. III. Correlation with Langerhans cells. J Periodontol 58: 417-422.
73. Sallusto F, Lanzavecchia A (2009). Heterogeneity of CD4+ memory T cells: functional modules for tailored immunity. Eur J Immunol 39: 2076-2082.
74. Saremi A, Nelson RG, Tulloch-Reid M et al (2005). Periodontal disease and mortality in type 2 diabetes. Diabetes Care 28: 27-32.
75. Scannapieco FA, Genco RJ (1999). Association of periodontal infections with atherosclerotic and pulmonary diseases. J Periodontal Res 34: 340-345.
76. Schwarz A, Noordegraaf M, Maeda A, Torii K, Clausen BE, Schwarz T (2010). Langerhans cells are required for UVR-induced immunosuppression. J Invest Dermatol 130: 1419-1427.
77. Seguier S, Godeau G, Leborgne M, Pivert G, Brousse N (2000). Quantitative morphological analysis of Langerhans cells in healthy and diseased human gingiva. Arch Oral Biol 45: 1073-1081.
78. Seguier S, Bodineau A, Godeau G, Pellat B, Brousse N (2003). Langerin+ versus CD1a+ Langerhans cells in human gingival tissue: a comparative and quantitative immunohistochemical study. Arch Oral Biol 48: 255-262.
79. Shin JE, Choi Y (2010). Treponema denticola suppresses expression of human beta-defensin-2 in gingival epithelial cells through inhibition of TNFalpha production and TLR2 activation. Mol Cells 29: 407-412.
80. Shin JE, Kim YS, Oh JE, Min BM, Choi Y (2010). Treponema denticola suppresses expression of human {beta}-defensin-3 in gingival epithelial cells through inhibition of the toll-like receptor 2 axis. Infect Immun 78: 672-679.
81. Shklovskaya E, O'Sullivan BJ, Ng LG et al (2011). Langerhans cells are precommitted to immune tolerance induction. Proc Natl Acad Sci U S A 108: 18049-18054.
82. Stashenko P, Goncalves RB, Lipkin B, Ficarelli A, Sasaki H, Campos-Neto A (2007). Th1 immune response promotes severe bone resorption caused by Porphyromonas gingivalis. Am J Pathol 170: 203-213.
83. Steinman RM (2007). Dendritic cells: understanding immunogenicity. Eur J Immunol 37(Suppl 1): S53-S60.
84. Steinman RM, Cohn ZA (1973). Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med 137: 1142-1162.
85. Steinman RM, Hawiger D, Nussenzweig MC (2003). Tolerogenic dendritic cells. Annu Rev Immunol 21: 685-711.
86. Stelin S, Ramakrishan H, Talwar A, Arun KV, Kumar TS (2009). Immunohistological analysis of CD1a langerhans cells and CD57 natural killer cells in healthy and diseased human gingival tissue: a comparative study. J Indian Soc Periodontol 13: 150-154.
87. Tam V, O'Brien-Simpson NM, Chen YY, Sanderson CJ, Kinnear B, Reynolds EC (2009). The RgpA-Kgp proteinase-adhesin complexes of Porphyromonas gingivalis Inactivate the Th2 cytokines interleukin-4 and interleukin-5. Infect Immun 77: 1451-1458.
88. Taylor GW, Burt BA, Becker MP et al (1996). Severe periodontitis and risk for poor glycemic control in patients with non-insulin-dependent diabetes mellitus. J Periodontol 67: 1085-1093.
89. Teng YT, Nguyen H, Gao X et al (2000). Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J Clin Invest 106: R59-R67.
90. van der Velden U (1991). The onset age of periodontal destruction. J Clin Periodontol 18: 380-383.
91. Vernal R, Leon R, Silva A, van Winkelhoff AJ, Garcia-Sanz JA, Sanz M (2009). Differential cytokine expression by human dendritic cells in response to different Porphyromonas gingivalis capsular serotypes. J Clin Periodontol 36: 823-829.
92. Walsh LJ, Seymour GJ, Savage NW (1986). Oral mucosal Langerhans cells express DR and DQ antigens. J Dent Res 65: 390-393.
93. Yin L, Chino T, Horst OV et al (2010). Differential and coordinated expression of defensins and cytokines by gingival epithelial cells and dendritic cells in response to oral bacteria. BMC Immunol 11: 37.
94. Yu JJ, Ruddy MJ, Wong GC et al (2007). An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. Blood 109: 3794-3802.
95. Yun PL, Decarlo AA, Collyer C, Hunter N (2001). Hydrolysis of interleukin-12 by Porphyromonas gingivalis major cysteine proteinases may affect local gamma interferon accumulation and the Th1 or Th2 T-cell phenotype in periodontitis. Infect Immun 69: 5650-5660.
96. Zavala WD, Cavicchia JC (2006). Deterioration of the Langerhans cell network of the human gingival epithelium with aging. Arch Oral Biol 51: 1150-1155.
97. Zeituni AE, Jotwani R, Carrion J, Cutler CW (2009). Targeting of DC-SIGN on human dendritic cells by minor fimbriated Porphyromonas gingivalis strains elicits a distinct effector T cell response. J Immunol 183: 5694-5704.